WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Cardlytics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-09 1:50 pm Sale | 2022-11-30 | 13G | Cardlytics, Inc. CDLX | WELLINGTON MANAGEMENT GROUP LLP | 18,531 0.060% | -1,932,876 (-99.05%) | Filing |
| 2022-09-09 10:26 am Sale | 2022-08-31 | 13G | Cardlytics, Inc. CDLX | WELLINGTON MANAGEMENT GROUP LLP | 1,951,407 5.930% | -1,902,608 (-49.37%) | Filing |
| 2022-02-04 09:15 am Purchase | 2021-12-31 | 13G | Cardlytics, Inc. CDLX | WELLINGTON MANAGEMENT GROUP LLP | 3,854,015 11.580% | 87,775 (+2.33%) | Filing |
| 2021-06-09 07:52 am Purchase | 2021-05-31 | 13G | Cardlytics, Inc. CDLX | WELLINGTON MANAGEMENT GROUP LLP | 3,766,240 11.460% | 1,959,449 (+108.45%) | Filing |
| 2021-02-03 2:14 pm Purchase | 2020-12-31 | 13G | Cardlytics, Inc. CDLX | WELLINGTON MANAGEMENT GROUP LLP | 1,806,791 6.580% | 113,301 (+6.69%) | Filing |